Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2003
08/28/2003WO2003070267A1 Enhancing the availability of minerals by using biologically active peptides
08/28/2003WO2003070265A2 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis
08/28/2003WO2003070229A2 Use of proteinase inhibitors in the treatment of autoimmune diseases
08/28/2003WO2003070221A1 Chemosensitizing with liposomes containing oligonucleotides
08/28/2003WO2003070220A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same
08/28/2003WO2003070197A2 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070196A2 Prevention of viral and bacterial disease in shrimp
08/28/2003WO2003070195A2 Biglycan and related therapeutics and methods of use
08/28/2003WO2003070193A2 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof
08/28/2003WO2003070189A2 Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003WO2003070176A2 Modified defensins and their use
08/28/2003WO2003070167A2 Therapeutic and prophylactic treatment of aging and disorders of aging in humans
08/28/2003WO2003070158A2 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
08/28/2003WO2003070157A2 Vitamin d upregulated protein 1 (vdup-1) methods and uses thereof
08/28/2003WO2003070083A2 Endothelial precursor cells for enhancing and restoring vascular function
08/28/2003WO2003070018A2 Food products comprising soy protein
08/28/2003WO2003070017A2 Novel soy protein products
08/28/2003WO2003070007A2 Method for manufacturing beads containing exogenous soy protein
08/28/2003WO2003070006A1 Bread comprising soy protein
08/28/2003WO2003062273A3 Modulator of the notch signalling pathway and use thereof in medical treatment
08/28/2003WO2003055911A3 Cystine-knot fold protein
08/28/2003WO2003053158A3 Malleable protein matrix and uses thereof
08/28/2003WO2003043986A8 Polypeptides of moraxella (branhamella) catarrhalis
08/28/2003WO2003038079A3 A mammalian mucinase, its recombinant production, and its use in therapy or prophylaxis against diseases in which mucus is involved or infectious diseases
08/28/2003WO2003035690A3 Hybrid and fusion polypeptide subunits of k+ channels
08/28/2003WO2003031467A3 Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament
08/28/2003WO2003031449A3 Cross-linked glycopeptide-cephalosporin antibiotics
08/28/2003WO2003029289A3 Fragements of heat shock proteins and their use
08/28/2003WO2003028840A3 Combined compositions and methods for tumor vasculature coagulation and treatment
08/28/2003WO2003028756A3 An in vivo animal model of chronic arterial occlusion and use of collagenase to facilitate guide wire crossing in chronic arterial occlusions
08/28/2003WO2003026602A3 Medicine for preventing and treating bromidrosis
08/28/2003WO2003025015A3 A soluble toll-like receptor
08/28/2003WO2003022858A3 Method for screening for inhibitors of protein/protein interaction and corresponding ribozymes
08/28/2003WO2003016522A3 Methods and compounds for the targeting of protein to exosomes
08/28/2003WO2003016335A3 Irreversible cysteine protease inhibitors of legumain
08/28/2003WO2003014153A3 Cellular virus receptors and methods of use.
08/28/2003WO2003014148A3 Human fatty acid-coa ligase
08/28/2003WO2003013434A3 Methods and compositions for treating diseases associated with excesses in ace
08/28/2003WO2003013429A3 A programmable electronic maze for use in the assessment of animal behaviour
08/28/2003WO2002102990A3 Fibroblast growth factor and nucleic acid encoding same
08/28/2003WO2002101043A3 Regulation of human ta4 receptor
08/28/2003WO2002101026A3 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms
08/28/2003WO2002100248A3 Compositions and methods relating to glucose metabolism, weight control, and food intake
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002096468A3 Method for the diagnosis and therapy of renal cell carcinoma
08/28/2003WO2002092787A3 Human secreted proteins
08/28/2003WO2002086093A9 Methods of using a hyaluronan receptor
08/28/2003WO2002083063A3 Method of improving systemic exposure of subcutaneously administered therapeutic proteins
08/28/2003WO2002081687A3 Yeast genes that affect viral replication
08/28/2003WO2002081628A8 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies
08/28/2003WO2002081521A3 Osteoprotegerin in milk
08/28/2003WO2002081517A3 Novel polypeptides and nucleic acids encoded thereby
08/28/2003WO2002077021A3 Streptococcus pneumoniae proteins and nucleic acids
08/28/2003WO2002074905A9 Leptin induced genes
08/28/2003WO2002074783A3 Modified interferon beta with reduced immunogenicity
08/28/2003WO2002074337A8 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
08/28/2003WO2002074293A3 Methods for restoring cognitive function following systemic stress
08/28/2003WO2002074048A8 P-glycoproteins and uses thereof
08/28/2003WO2002072823A3 Human g protein-coupled receptor
08/28/2003WO2002070006A3 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
08/28/2003WO2002068687A3 Function and application of tob gene in central nervous system of mammal
08/28/2003WO2002068469A3 Modified thrombopoietin with reduced immunogenicity
08/28/2003WO2002062369A3 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
08/28/2003WO2002048310A3 Methods and compositions for diagnosing and treating rheumatoid arthritis
08/28/2003WO2002044736A3 Diagnosis and treatment of epidermal or skin diseases
08/28/2003WO2002043771A3 Conjugates of glycosylated/galactosylated peptide
08/28/2003WO2002040539A3 Gpcr-like protein and nucleic acids encoding same
08/28/2003WO2002036627A3 Interferons, uses and compositions related thereto
08/28/2003WO2002036149A3 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof
08/28/2003WO2002027022A3 Methods for diagnosing and treating autosomal dominant optic atrophy
08/28/2003WO2002026818A3 Human nedd-1
08/28/2003WO2002026776A3 Peptide-based compounds
08/28/2003WO2002020756A3 Secretory molecules
08/28/2003WO2002012326A3 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
08/28/2003WO2002009642A3 Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel
08/28/2003WO2002008399A3 Human kinases
08/28/2003WO2002007752A3 Red blood cell as vehicle for agent-membrane translocation sequence conjugate
08/28/2003WO2002000839A3 Statement as to federally sponsored research
08/28/2003WO2001092307A3 Therapeutic compounds for ovarian cancer
08/28/2003WO2001082949A3 Method of reducing side effects of chemotherapy in cancer patients
08/28/2003WO2001079489A3 39228, a human alcohol dehydrogenase and uses therefor
08/28/2003WO2001077167A3 Methods of investigating, diagnosing, and treating amyloidosis
08/28/2003US20030163845 Elongase genes and uses thereof
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
08/28/2003US20030162955 Isolated mammalian membrane protein genes; related reagents
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162948 Tumour necrosis factor binding ligands
08/28/2003US20030162945 G- protein coupled receptor org10
08/28/2003US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
08/28/2003US20030162943 Antibodies to polypeptide molecules of the G protein-coupled heptahelical receptor superfamily and uses therefor
08/28/2003US20030162820 Heterocyclic amides used as dipeptidyl aminopeptidase (DPIV) inhibitors, for prophylaxis of arthritis, obesity, allograft surgery, cancer, autoimmune, nervous system and skin disorders
08/28/2003US20030162807 Compositions and methods for treating osteoporosis and lowering cholesterol
08/28/2003US20030162768 Treatment of Alzheimer's disease
08/28/2003US20030162748 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen
08/28/2003US20030162738 Antigenic composition comprising a polycationic peptide and inosine and cytosine
08/28/2003US20030162737 Preventives and remedies for pulmonary hypertension
1 ... 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 ... 3163